List of Lycera patents

Patents where

Current Assignee

Name

Lycera

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10532088 Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods	Patent 10532088 was granted and assigned to Lycera on January, 2020 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10532088	January 14, 2020
‌ US Patent 10208061 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease	Patent 10208061 was granted and assigned to Lycera on February, 2019 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10208061	February 19, 2019
‌ US Patent 10421751 Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease	Patent 10421751 was granted and assigned to Lycera on September, 2019 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10421751	September 24, 2019
‌ US Patent 9370507 Pyridonyl guanidine F	Patent 9370507 was granted and assigned to Lycera on June, 2016 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9370507	June 21, 2016
‌ US Patent 10611740 Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease		Lycera	Lycera	United States Patent and Trademark Office	10611740	April 7, 2020
‌ US Patent 10442798 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease	Patent 10442798 was granted and assigned to Lycera on October, 2019 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10442798	October 15, 2019
‌ US Patent 10364237 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease	Patent 10364237 was granted and assigned to Lycera on July, 2019 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10364237	July 30, 2019
‌ US Patent 9580388 Pyrazolyl guanidine F	Patent 9580388 was granted and assigned to Lycera on February, 2017 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9580388	February 28, 2017
‌ US Patent 9266839 Trifluoromethyl pyrazolyl guanidine F	Patent 9266839 was granted and assigned to Lycera on February, 2016 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9266839	February 23, 2016
‌ US Patent 9580391 Saturated acyl guanidine for inhibition of F	Patent 9580391 was granted and assigned to Lycera on February, 2017 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9580391	February 28, 2017
‌ US Patent 10085972 Trifluoromethyl pyrazolyl guanidine F	Patent 10085972 was granted and assigned to Lycera on October, 2018 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10085972	October 2, 2018
‌ US Patent 10112935 Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease	Patent 10112935 was granted and assigned to Lycera on October, 2018 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10112935	October 30, 2018
‌ US Patent 9914706 N-substituted pyrazolyl guanidine F	Patent 9914706 was granted and assigned to Lycera on March, 2018 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9914706	March 13, 2018
‌ US Patent 9802958 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease	Patent 9802958 was granted and assigned to Lycera on October, 2017 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9802958	October 31, 2017
‌ US Patent 9896441 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease	Patent 9896441 was granted and assigned to Lycera on February, 2018 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9896441	February 20, 2018
‌ US Patent 9815791 Alkylpyrazolyl guanidine F	Patent 9815791 was granted and assigned to Lycera on November, 2017 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9815791	November 14, 2017
‌ US Patent 10189777 Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease	Patent 10189777 was granted and assigned to Lycera on January, 2019 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10189777	January 29, 2019
‌ US Patent 9221814 Heterocyclic guanidine F	Patent 9221814 was granted and assigned to Lycera on December, 2015 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9221814	December 29, 2015
‌ US Patent 9394315 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease	Patent 9394315 was granted and assigned to Lycera on July, 2016 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9394315	July 19, 2016
‌ US Patent 10392350 N-substituted pyrazolyl guanidine F	Patent 10392350 was granted and assigned to Lycera on August, 2019 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10392350	August 27, 2019
‌ US Patent 9707211 Trifluoromethyl pyrazolyl guanidine F	Patent 9707211 was granted and assigned to Lycera on July, 2017 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9707211	July 18, 2017
‌ US Patent 9169199 Cycloalkyl guanidine F	Patent 9169199 was granted and assigned to Lycera on October, 2015 by the United States Patent and Trademark Office.		Lycera	United States Patent and Trademark Office	9169199	October 27, 2015
‌ US Patent 9139532 Pyrazolyl guanidine F	Patent 9139532 was granted and assigned to Lycera on September, 2015 by the United States Patent and Trademark Office.		Lycera	United States Patent and Trademark Office	9139532	September 22, 2015
‌ US Patent 9920012 Indazole guanidine F	Patent 9920012 was granted and assigned to Lycera on March, 2018 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	9920012	March 20, 2018
‌ US Patent 10556898 Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease	Patent 10556898 was granted and assigned to Lycera on February, 2020 by the United States Patent and Trademark Office.	Lycera	Lycera	United States Patent and Trademark Office	10556898	February 11, 2020

Results per page:

28 results

0 selected

28 results

0 selected